Physician profile
Michael Raymond Manogue
NPI 1417183054
$230,062.86
in general payments reported to CMS, 2019-2025
22 companies · $147K in 2025
The $147K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,187 · 2020: $6,552 · 2021: $3,089 · 2022: $7,541 · 2023: $22K · 2024: $40K · 2025: $147K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $160K · Consulting Fee: $25K · Food and Beverage: $15K · Travel and Lodging: $8,715 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $159,839.00 |
| Consulting Fee | $25,087.50 |
| Food and Beverage | $14,932.50 |
| Travel and Lodging | $8,714.51 |
| Education | $120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $155,882.65 | 2019-2025 | General - Ep, Farapulse, Rhythmia Mapping System |
| Medtronic, INC. | $62,678.64 | 2021-2025 | Selectsecure, Azure Xt Dr Mri Surescan, Micra |
| Medtronic Vascular, INC. | $4,879.82 | 2019-2020 | |
| Biosense Webster, INC. | $3,754.24 | 2021-2024 | Carto 3 |
| Abbott Laboratories | $695.07 | 2021-2025 | Ensite, Viewmate, Amplatzer |
| Atricure, INC. | $486.07 | 2022-2024 | |
| Biotronik INC. | $382.11 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Actelion Pharmaceuticals US, INC. | $257.55 | 2019-2020 | |
| Vektor Medical INC. | $251.64 | 2025 | Vmap |
| Pfizer INC. | $168.04 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $115.03 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $114.99 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.46 | 2024-2025 | Jardiance |
| Amarin Pharma, INC. | $55.95 | 2019-2020 | |
| Terumo Medical Corporation | $46.39 | 2024 | Metacross Otw, Glidewire, Heartrail |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $44.24 | 2023-2024 | Eliquis |
| Amgen INC. | $38.11 | 2019 | |
| United Therapeutics Corporation | $32.25 | 2019 | |
| Cardiva Medical, INC. | $27.61 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novartis Pharmaceuticals Corporation | $26.76 | 2019-2020 | |
| Edwards Lifesciences Corporation | $21.04 | 2024 | Hemosphere |
| Bayer Healthcare Pharmaceuticals INC. | $19.20 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Manogue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.